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The issue of co-morbidity in Anxiety and Depression as disorders leads to questions about the 
integrity of their present taxonomies in mental health diagnostics. At face value the two appear to 
have discrete differences, yet nonetheless demonstrate a high co-morbidity rate and shared symptoms 
implying pathological similarities rather than that of chance. Reviewing evidence from behavioural, 
neural, and biological sources that elaborate on the aspects of these two constructs, helps to illustrate 
the nature of these apparent differences and similarities. Integrating evidence from the anxiety and 
depression literature with the pathological process best illustrated by the burnout theory, alongside 
with support from the neurobiology of anxiety and stress, presents a proposition of a basic and 
natural anxiety pathology that when excessive, may result in the symptoms psychology has come to 
know as representative of anxiety and depressive disorders.  
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The Problem of Comorbidity 
Both the Diagnostic and Statistic Manual of Mental Disorders (DSM) and International 
Statistical Classification of Diseases and Related Health Problems (ICD) categorise anxiety 
and depression as different types of mental disorder. The ICD-10 categorises anxiety 
disorders as part of the spectrum of neurotic, stress-related and somatoform disorders, and 
depression under mood/affective disorders.
1
 Although formerly under different sections in 
earlier versions, the recent DSM-5 places these in a general mental disorder category, with 
categories specific to depressive disorders and anxiety disorders, and further subdivided into 
different variations.
2
 Despite terminological differences, the two associate anxiety disorders 
with anxious and fearful psychological and physiological symptoms, and depressive disorders 
with low mood, motivation, and negative affect. An estimated quarter of the population of the 
Untied States of America are estimated to have been afflicted by an anxiety disorder within 
                                                          
1
 International Statistical Classification of Diseases and Related Health Problems, World Health Organisation 
(Geneva: WHO Press, 2010) 
2
 Diagnostic and statistical manual of mental disorders, American Psychiatric Association (Washington, DC: 
Author, 2013). 




 Sanderson, Di Nardo, Rapee, and Barlow find that up to 90% of people 
diagnosed with anxiety disorders suffer from another mental disorder.
4
 Amongst anxiety 
disorders co-morbidity ranges from 10% to 15% with depressive disorders, whilst depressive 
disorder's co-morbidity with anxiety disorders range from 15% to 75%.
5
 This review shall 
investigate this apparent problem of co-morbidity and whether they are two taxonomically 
different pathologies or aspects of a single pathology. 
The Behavioural Standpoint 
The tripartite model attempts to resolve the co-morbidity issue by suggesting that anxiety and 
depression are separate disorders that share a significant common factor.
6
 Their reasoning in 
summary is that anxiety is a hyperarousal disorder and depression is an anhendonic disorder, 
and that hyperarousal fails to account for depressive symptoms and likewise anhedonia fails 
to account for anxiety symptoms; therefore negative affective is the common symptom that 
explains the prevalence of co-morbidity
7,8
. Rather than negative affect, some researchers 
prefer the concept of neuroticism as the major common factor.
9,10
 According to Wetherell et 
al., the results of their longitudinal study imply that anxiety symptoms lead to depression 
more so than depression symptoms to anxiety, a reflection of the earlier stated rates of 
depression's co-morbidity with anxiety (15%-75%).
11
 In this same study, analysis revealed a 
correlation of .84 between factors of anxiety and depression in young adults and the authors 
posit neuroticism as the common factor for vulnerability to anxious and depressive disorders. 
It is important to note that the premise that the disorders are different in such examples is 
based upon behaviours, as they present polarised core behaviours and are therefore assumed 
and classed as different.  
Neuroimaging Anxiety and Depression 
The prefrontal cortex (PFC) is the seat of cognitive and emotional processing.
12
 People self-
reporting higher levels of behavioural inhibition, which is correlated with avoidance, anxiety, 
and neuroticism,
13
 demonstrate higher levels of activity in the right dorsolateral PFC 
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 In healthy pathologically low anxiety individuals, threatening stimuli increase 
activity in the PFC, whilst high anxiety participants are less responsive.
15
 Despite this lower 
activity, individuals with generalised anxiety disorder posses higher levels of metabolism in 
the dPFC.
16,17
 Depression too is associated with reduced activity in the dPFC.
18
 Furthermore 
extensive damage to multiple areas in the PFC is positively associated with depressive 
symptoms, with damage to the dPFC regions rendering the most severe symptoms.
19
  
The amygdala modulates fear responses.
20
 Increased amygdala activity has been 
linked to decreased dPFC activity in both healthy and depressed individuals.
21,22,23
 However 
amygdala activity varies amongst depressed individuals, with some possessing above average 
volume and activity, and others reduced volume and activity compared to healthy individuals, 
which Sacher et al. propose may signify the respective differences between individuals 
suffering from first episodes of major depression and those with recurring episodes.
24
  
The hippocampus is known to be the core area of the brain dedicated to memory, 
having an impact on all memory related cognition.
25
 Anxiety in general is associated with 
increased activity in the anterior hippocampus, and state anxiety with the addition of 
increased connectivity with the PFC.
26
 State anxiety is the conscious cognitive perception of 
threats, reflected in PFC activity, whilst the more automatic trait anxiety response is 
associated with connectivity to the more sensory and unconscious posterior cortical regions 
of the brain.
27
 Depression however is associated with atrophy throughout hippocampus.
28,29
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The anterior cingulate cortex (ACC) is associated with memory recall.
30
 In 
adolescents, rumination was associated with an increased likelihood of developing 
depression, having had a past depressive episode, and the duration and severity of depressive 
episodes.
31,32
 Depression often shows greater subgenual ACC activity and metabolism, with 
correlation to ruminative tendencies.
33,34,35
 Furthermore the degree of ACC responsiveness to 
social stresses is positively correlated with the onset of depressive symptoms.
36
 Diminished 
ACC activity in depression however is negatively correlated with recovery rates.
37
 
Considering anxiety has an earlier age of onset than depression and predicts depression later 
in life,
38,39,40
 would appear to imply that responsiveness to perceived threats or stresses and 
the chronic re-experience of these in the form of rumination may play a role in the onset of 
depression and its ongoing severity. 
Thus the behavioural and neurological states are polarised in the disorders of anxiety 
and depression. However considering there are studies that find anxiety precedes depression 
and is even predictive of depressive episodes in individuals,
41,42,43,44
 one may propose some 
relation exists from one to the other. This very hypothesis has been posited indirectly by the 
occupational burnout hypothesis. The concept of burnout outlines how individuals suffering 
from anxieties and strains in the form of occupational stress are more likely to be exhausted 
and develop depressive symptoms.
45,46
 Factors such as neuroticism, gender, financial strain, 
job satisfaction, domestic issues, chronic medical illness, and depressive symptoms are 
identified as specific stressors related to the severity of burnout over time.
47
 Bianchi, 
Schonfeld & Laurent found that 90% of their participants identified as burned out using a 
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psychometric burnout scale met the DSM-IV criterion for depression, and that increased 
ratings of burnout correlated with increased severity of depressive symptoms.
48
 Thus it is 
implied according to the burnout theory, that excessive anxiety and stress over time has an 
influence on the onset depressive symptoms. 
Biochemical Evidence of an Anxious Pathology 
 The evidence that can tie the behavioural and neuroimaged observations, is the role of 
excitatory neurotransmitters. It is worth noting that the word anxiety itself and its symptoms 
imply anticipatory psychological and physiological arousal. Vital to this process is glutamate, 
an excitatory neurotransmitter that stimulates the activity of the sympathetic nervous system 
and accounts for up to 50-60% of neurotransmission in the brain.
49
 Although essential for 
basic functioning and survival, the neurotoxicity of excessive glutamate upon neurons is 
noteworthy.
50,51,52,53
 In rats developmental stresses facilitated and increased glutamate release 
in the amygdala.
54
 Considering the amygdala's connectivity to various regions of the brain,
55
 
such sensitisation may trigger a cascading fear/anxiety response throughout the brain. 
Furthermore chronic stress also reduces functioning and damages neurons in the 
hippocampus and PFC, the precise areas found damaged in depressive disorders.
56,57,58
  
Glutamate antagonists are effective as antidepressant medications, and many present 
antidepressants and anxiety treating benzodiazepines interfere with and reduce glutamate 
release and uptake.
59,60,61
 It is also noteworthy that many popular informal drugs such as 
alcohol, cannabis, and non-steroidal anti-inflammatory drugs (e.g. acetaminophen, aspirin, 
ibuprofen) all either suppress release or suppress uptake of glutamate in the brain,
62,63,64,65
 
                                                          
48
 R. Bianchi, I. S. Schonfeld, and E. Laurent, “Is Burnout a Depressive Disorder? A Reexamination With 
Special Focus on Atypical Depression,” International Journal of Stress Management 21, no. 4 (2014), doi: 
10.1037/a0037906. 
49
 J. M. Wierońska et al., “Depression Viewed as a GABA/Glutamate Imbalance in the Central Nervous 
System,” in Clinical, Research and Treatment Approaches to Affective Disorders, ed. M. Juruena (Rijeka, 
Croatia: InTech, 2012). 
50
 T. A. Azami et al., “Regional Regulation of Glutamate Signaling During Cuprizone-Induced Demyelination 
in the Brain,” Annals of Anatomy 195, no. 5 (2013), doi: 10.1016/j.aanat.2013.03.004. 
51
 D. W. Choi, M. Maulucci-Gedde, and A. R. Kriegstein, “Glutamate Neurotoxicity in Cortical Cell Culture,” 
Journal of Neuroscience 7, no. 2 (1987). 
52
 M. Frigo et al., “Glutamate and Multiple Sclerosis,” Current Medical Chemistry 19, no. 9 (2012), doi: 
10.1515/revneuro-2012-0062. 
53
 A. Lau, and M.Tymianski, “Glutamate Receptors, Neurotoxicity and Neurodegeneration,” Pflügers Archiv 
460, no. 2 (2010), doi: 10.1007/s00424-010-0809-1. 
54
 S. Tzanoulinou et al., “Long-Term Behavioral Programming Induced by Peripuberty Stress in Rats Is 
Accompanied by GABAergic- Related Alterations in the Amygdala,” PLoS ONE 9, no. 4 (2014) doi: 
10.1371/journal.pone.0094666. 
55
 A. Roy et al., “Functional Connectivity of the Human Amygdala using Resting State fMRI,” Neuroimage 45, 
no. 2 (2009), doi: 10.1016/j.neuroimage.2008.11.030. 
56
 McEwen, “Effects of Adverse Experiences.” 
57
 Sapolsky, “The Possibility of Neurotoxicity in the Hippocampus.” 
58
 M. Popoli et al., “The Stressed Synapse: the Impact of Stress and Glucocorticoids on Glutamate 
Transmission,” Nature Review of Neuroscience 13 (2013), doi: 10.1038/nrn3138. 
59
 A. Medina et al., “Glutamate Transporters: a Key Piece in the Glutamate Puzzle of Major Depressive 
Disorder,” Journal of Psychiatric Research 47, no. 9 (2013), doi: 10.1016/j.jpsychires.2013.04.007. 
60
 L. Musazzi et al., “The Action of Antidepressants on the Glutamate System: Regulation of Glutamate Release 
and Glutamate Receptors,” Biological Psychiatry 73, no. 12 (2013), doi: 10.1016/j.biopsych.2012.11.009. 
61
 A. J. Delaney, and P. Sah, “GABA Receptors Inhibited by Benzodiazepines Mediate Fast Inhibitory 
Transmission in the Central Amygdala,” The Jounal of Neuroscience 19, no. 22 (1999). 
62
 T. M. Brown, J. M. Brotchie, and S. M. Fitzjohn, “Cannabinoids Decrease Corticostriatal Synaptic 
Transmission via an Effect on Glutamte Uptake,” The Journal of Neuroscience 23, no. 35 (2003). 
   Steven Carey   •   15 
 
giving insight into the prevalence of drug use in anxiety and mood disorders.
66,67
 Thus the 
neural damage of depression could be caused by an excess of stress related neurochemicals, 
which although essential for activity and functioning, in excess result in neurological damage. 
These effects are reflected in visible energy levels, cognitive abilities, and compensatory (e.g. 
self-medicating) behaviours common to anxiety and depression. 
Biomarkers in the blood have been indicated for both anxiety and depression in the 
form of cholesterol, with heightened levels of high-density lipoprotein (HDL) associated with 
heightened levels of anxiety and depression, and higher levels of low-density lipoprotein 
(LDL) with lower levels of anxiety and depression.
68,69
 Curiously the excitatory hormone and 
neurotransmitter epinephrine significantly increases HDL cholesterol in the bloodstream,
70
 
while the similar norepinephrine reduces LDL cholesterol.
71
 Thus stress has a direct effect on 
the prevalence of these biomarkers. Of further interest is cholesterol's essential role in the 
biosynthesis of testosterone,
72
 and that HDL cholesterol positively associates with 
testosterone and yet is reduced by its presence.
73,74,75
 The importance of the previous sentence 
is that when testosterone binds to androgen receptors in the brain, it demonstrates protective 
and reparative effects.
76,77
 Thus a reasonable suggestion can be made that stress plays an 
important role in stimulating an increase in HDL cholesterol, effectively increasing 
testosterone production, of which upon binding to androgen receptors protects and or repairs 
stress related neurological damage. In an animal studies regarding chronic stress, higher 
levels of the feminine hormone estradiol resulted in augmented physiological stress, while 
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higher levels of the masculine hormone testosterone attenuated physiological stress.
78
 These 
observations may offer an explanation towards the demographics in depression where women 
are around 33% more likely to suffer from depression in their lifetimes than men.
79
 An 
additional curiosity from animal studies is the related restorative effects of mild exercise 
upon the neurons of the hippocampus,
80
 and may further suggest the biology of the 




 In conclusion, based on pure observation of behavioural symptoms, anxiety and depression 
are different disorders. Neuroimaging the two disorders reflects the behavioural interpretation 
through the mostly polarised activity between normal anxiety responses and severe 
depression. Yet when one proposes the hypothesis that chronic anxiety leads to neural 
damage, the disorders then lie upon a spectrum of the severity and duration of anxious 
cognitions and behaviours and the resulting neurological damage, thus appearing to be a 
single pathology. The biochemical evidence would support this hypothesis of the two 
behaviours being of the same biological mechanism, clarifying depression as a later 
consequence of an anxious psychopathology. The author's personal observation is that the 
psychophysiological stress response to external threats appears to be similar to what the 
immune response is to internal threats, and that both in excess enact detrimental effects (see 
Tisconik et al. for an analogous theory in immunology, i.e. the cytokine storm
83
).  
There is also a curious irony of some research declaring neuroticism as the common 
factor between depression and anxiety, without acknowledging the physiological effects of 
neurological stress upon anxiety and depression, as the linguistic morphology of 
“neuroticism” represents a state inclined towards “neurosis”, meaning anxiety, tension, and 
arousal of the nervous system. Linguistically therefore, anxious behaviours are essentially 
manifestations of neurosis and the two terms can be considered interchangeable, as is 
indicated by the psychophysiological evidence. Yet it is entirely understandable following the 
empirical strength of behavioural studies in the earlier half of the previous century and to this 
day, alongside the lack of present technology in the past, that the behavioural symptoms and 
thence terminology were the primary means of consolidating the present taxonomy of mental 
illness. Considering this perspective however, unless a strictly behavioural premise for 
taxonomy is the focus for diagnosis and treatment, the current ICD-10 and DSM-5 diagnostic 
criteria may misrepresent the psychopathological nature of mental illness in the case of 
anxiety and more so depression. From a psychopathological standpoint, a reasonable 
argument can be made that anxiety and depression are part of the same underlying pathology. 
This single disorder perspective also offers insight into the widespread success of single 
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process therapies upon numerous and supposedly different disorders.
84
 Where considering a 
possible singular psychopathological model of these disorders would likely be of greatest 
importance is in refining measures of prevention, intervention, and, when required, recovery 
oriented medication of mental illness through detailed study and understanding of this 
underlying anxiety psychopathology. 
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